Skip to main content

Table 1 Characteristics of study cohort

From: GPER-1 acts as a tumor suppressor in ovarian cancer

Characteristic N of patients GPER-1 p-value
Negative Positive
N (%) N (%)
Total 124 21 (16.9) 103 (83.1)  
Age, years (range) 124 65 (30–84) 61 (20–85) 0.136
Menopausal status     
   premenopausal 16 1 (6.2) 15 (93.8)  
   postmenopausal 108 20 (18.5) 88 (81.5) 0.304
FIGO Stage     
   1 25 0 (0) 25 (100)  
   2 21 6 (28.6) 15 (71.4)  
   3 76 14 (18.4) 62 (81.6)  
   4 2 1 (50.0) 1 (50) 0.032
Lymph node status     
   negative 31 5 (16.1) 26 (83.9)  
   positive 18 3 (16.7) 15 (83.3) 1.000
Histological grading     
   1 18 0 (0) 18 (100)  
   2 38 7 (18.4) 31 (81.6)  
   3 68 14 (20.6) 54 (79.4) 0.112
Histology     
   serous 81 13 (16.0) 68 (84.0)  
   mucinous 16 3 (18.8) 13 (81.2)  
   endometrioid 13 2 (15.4) 11 (84.6)  
   clear cell 8 0 (0) 8 (100)  
   other 6 3 (50) 3 (50) 0.171
Recurrence (in 24 months)     
   no 57 4 (7.0) 53 (93.0)  
   yes 67 17 (25.4) 50 (74.6) 0.008